BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 12428206)

  • 21. Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Mébarki F; Sanchez R; Rhéaume E; Laflamme N; Simard J; Forest MG; Bey-Omar F; David M; Labrie F; Morel Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2127-34. PubMed ID: 7608265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E; Sanchez R; Simard J; Chang YT; Wang J; Pang S; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT; Kappy MS; Iwamoto K; Wang J; Yang X; Pang S
    Pediatr Res; 1993 Nov; 34(5):698-700. PubMed ID: 8284113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Δ5-steroids.
    Takasawa K; Ono M; Hijikata A; Matsubara Y; Katsumata N; Takagi M; Morio T; Ohara O; Kashimada K; Mizutani S
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):782-9. PubMed ID: 24372086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCAAT/enhancer-binding protein β is involved in the breed-dependent transcriptional regulation of 3β-hydroxysteroid dehydrogenase/Δ(5)-Δ(4)-isomerase in adrenal gland of preweaning piglets.
    Li X; Li R; Jia Y; Sun Z; Yang X; Sun Q; Zhao R
    J Steroid Biochem Mol Biol; 2013 Nov; 138():273-80. PubMed ID: 23831357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural aspects of the p.P222Q homozygous mutation of HSD3B2 gene in a patient with congenital adrenal hyperplasia.
    Lusa LG; Lemos-Marini SH; Soardi FC; Ferraz LF; Guerra-Júnior G; Mello MP
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):768-74. PubMed ID: 21340167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase deficiency].
    Marunová M
    Vnitr Lek; 2006 Oct; 52(10):957-62. PubMed ID: 17063810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity.
    Lachance Y; Luu-The V; Verreault H; Dumont M; Rhéaume E; Leblanc G; Labrie F
    DNA Cell Biol; 1991 Dec; 10(10):701-11. PubMed ID: 1741954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin.
    Simard J; Rhéaume E; Leblanc JF; Wallis SC; Joplin GF; Gilbey S; Allanson J; Mettler G; Bettendorf M; Heinrich U
    Hum Mol Genet; 1994 Feb; 3(2):327-30. PubMed ID: 8004103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents.
    Nayak S; Lee PA; Witchel SF
    Mol Genet Metab; 1998 Jul; 64(3):184-92. PubMed ID: 9719627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3β-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency.
    Jeandron DD; Sahakitrungruang T
    Horm Res Paediatr; 2012; 77(5):334-8. PubMed ID: 22343390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord.
    Saredi S; Patte-Mensah C; Melcangi RC; Mensah-Nyagan AG
    Neuroscience; 2005; 135(3):869-77. PubMed ID: 16111823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.
    Gingras S; Simard J
    Endocrinology; 1999 Oct; 140(10):4573-84. PubMed ID: 10499513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning, expression, and physical mapping of the 3beta-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human.
    McBride MW; McVie AJ; Burridge SM; Brintnell B; Craig N; Wallace AM; Wilson RH; Varley J; Sutcliffe RG
    Genomics; 1999 Nov; 61(3):277-84. PubMed ID: 10552929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human-type 1 3beta-hydroxysteroid deshydrogenase/Delta(5)-Delta(4)-isomerase expression using siRNA.
    Samson M; Labrie F; Luu-The V
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):253-7. PubMed ID: 15862972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 3beta-hydroxysteroid dehydrogenases from gonads of the Nile tilapia: phylogenetic significance and expression during reproductive cycle.
    Senthilkumaran B; Sudhakumari CC; Wang DS; Sreenivasulu G; Kobayashi T; Kobayashi HK; Yoshikuni M; Nagahama Y
    Mol Cell Endocrinol; 2009 Feb; 299(2):146-52. PubMed ID: 19084575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder.
    Zhang L; Mason JI; Naiki Y; Copeland KC; Castro-Magana M; Gordon-Walker TT; Chang YT; Pang S
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1678-85. PubMed ID: 10770215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.